Current Assets
Available-for-Sale Debt Securities - Amortized Cost
Amgen Available-for-Sale Debt Securities - Amortized Cost increased by 34.7% to $11.48B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 38.3%, from $8.30B to $11.48B. Over 5 years (FY 2020 to FY 2025), Available-for-Sale Debt Securities - Amortized Cost shows a downward trend with a -2.8% CAGR.
Analysis
StatementBalance Sheet Statement
SectionCurrent Assets
CategoryLiquidity
SignalContext dependent
VolatilityModerate
First reportedQ2 2018
Last reportedQ1 2026Apr 30, 2026
How to read this metric
Changes reflect shifts in the company's liquidity management strategy and the size of its investment portfolio.
Detailed definition
This is the cost basis of debt securities classified as available-for-sale, adjusted for amortization of premiums or dis...
Peer comparison
Standard metric for any corporation holding a significant portfolio of marketable debt securities.
Metric ID:
afs_debt_securities_amortized_costHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $7.16B | $12.28B | $7.30B | $5.85B | $6.41B | $10.92B | $4.34B | $31.07B | $33.62B | $34.21B | $10.40B | $9.24B | $8.81B | $8.58B | $11.49B | $8.30B | $7.49B | $8.71B | $8.53B | $11.48B |
| QoQ Change | — | +71.5% | -40.5% | -19.9% | +9.6% | +70.3% | -60.3% | +616.6% | +8.2% | +1.8% | -69.6% | -11.2% | -4.6% | -2.7% | +33.9% | -27.7% | -9.8% | +16.3% | -2.1% | +34.7% |
| YoY Change | — | — | — | — | -10.4% | -11.0% | -40.6% | +430.8% | +424.2% | +213.2% | +140.0% | -70.3% | -73.8% | -74.9% | +10.4% | -10.1% | -15.0% | +1.5% | -25.8% | +38.3% |
Range$4.34B – $34.21B
CAGR+10.5%
Avg YoY Growth+57.9%
Median YoY Growth-10.3%
Available-for-Sale Debt Securities - Amortized Cost at Other Companies
Frequently Asked Questions
- What is Amgen's available-for-sale debt securities - amortized cost?
- Amgen (AMGN) reported available-for-sale debt securities - amortized cost of $11.48B in Q1 2026.
- How has Amgen's available-for-sale debt securities - amortized cost changed year-over-year?
- Amgen's available-for-sale debt securities - amortized cost increased by 38.3% year-over-year, from $8.30B to $11.48B.
- What is the long-term trend for Amgen's available-for-sale debt securities - amortized cost?
- Over 5 years (2020 to 2025), Amgen's available-for-sale debt securities - amortized cost has grown at a -2.8% compound annual growth rate (CAGR), from $9.84B to $8.53B.
- What does available-for-sale debt securities - amortized cost mean?
- The original purchase price of debt investments adjusted for accounting premiums or discounts.